Warning letter
Gaspari Nutrition, Inc. [ARCHIVED]: warning letter of Mar 2, 2011
FDA warning letter 145292 · New Jersey District Office
Key facts
| Reference number | 145292 |
|---|---|
| Company | Gaspari Nutrition, Inc. [ARCHIVED] |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Mar 2, 2011 |
| Posted date | Mar 2, 2011 |
| Issuing office | New Jersey District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.553, 111.560(a), 111.560(a)(2) |
| Inspection city | Lakewood |
| Inspection ZIP | 08701 |
| Inspection start date | Sep 27, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: